Law firm probes Stryker for possible securities law breaches after conflicting manufacturing updates.

Block & Leviton is investigating Stryker Corporation for potentially misleading investors about a manufacturing issue affecting its peripheral vascular business. Initially, Stryker's CEO claimed the problem was resolved and expected to be fixed in Q3 2026, but the CFO later revealed it remained unresolved and would continue into Q4, causing an 8% stock drop. The investigation focuses on whether Stryker misrepresented the situation to investors. Affected investors are encouraged to contact the law firm for possible recovery of losses.